2015
DOI: 10.5935/0004-2749.20150065
|View full text |Cite
|
Sign up to set email alerts
|

Postoperative fungal endophthalmitis caused by Trichosporon asahii treated with voriconazole

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
4
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 6 publications
1
4
0
Order By: Relevance
“…Furthermore, poorly controlled diabetes mellitus likely predisposed our patient to this infection, similarly as reported by Saban Gonul et al in their publication [5].…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…Furthermore, poorly controlled diabetes mellitus likely predisposed our patient to this infection, similarly as reported by Saban Gonul et al in their publication [5].…”
Section: Discussionsupporting
confidence: 83%
“…There are reports of exogenous endophthalmitis caused by Trichosporon asahii and cutaneoum with positive cultures acquired from the intraocular lens and structures of the enucleated eye, respectively [ 3 , 5 ]. As stated earlier, this species of fungi is a commensal of the skin, including the hair follicles.…”
Section: Discussionmentioning
confidence: 99%
“…Studies showed that voriconazole was the rst choice for drug treatment of a. asasicum, followed by itraconazole and uconazole [21][22][23][24], and drug resistance to carpofennet and amphotericin B [25][26][27]. Some reports suggest that there are regional differences in sensitivity to amphotericin B, with most drug resistance in foreign countries, but still sensitivity in mainland China [25,27].…”
Section: Discussionmentioning
confidence: 99%
“…Once trichosporonosis has established in tissue, recurrence is common even with prolonged antifungal treatment of up to 2 years. 8,9 In this case, duration of intravenous antimicrobial treatment was guided by clinical improvement and monitoring of inflammatory markers; we switched intravenous to oral treatment approximately 1 month after all inflammatory markers (C-reactive protein [CRP], procalcitonin, erythrocyte sedimentation rate [ESR]) in our patient had normalised. Treatment in this case was complicated by initial intolerance to voriconazole, requiring a switch to a regimen that was potentially less effective (amphotericin and fluconazole).…”
Section: Discussionmentioning
confidence: 99%